Gregory Frost

Company: Exuma Biotechnology

Job title: Chairman & Chief Executive Officer

Seminars:

Investigating Strategies to Refine Translational Outcomes & Direct Future Advancements 4:30 pm

Discussing strategies to effectively triangulate preclinical models to decrease the variability of translational outcomes Showcasing accurate translational data utilizing methods triangulating preclinical models Exploring future advancements in preclinical models to further enhance translational precision Read more

day: Day One